<!doctype html>
<html data-n-head-ssr>
  <head>
    <title>药品网站</title><meta data-n-head="ssr" charset="utf-8"><meta data-n-head="ssr" name="viewport" content="width=device-width,initial-scale=1"><meta data-n-head="ssr" data-hid="description" name="description" content=""><link data-n-head="ssr" rel="icon" type="image/x-icon" href="/favicon.ico"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/runtime.c707a1a.js" as="script"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/commons.app.5f7b08b.js" as="script"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/vendors.app.2feb4b5.css" as="style"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/vendors.app.fcf2fc9.js" as="script"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/app.c4b7f37.css" as="style"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/app.9269d96.js" as="script"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/pages/newsdetail/_id.acd4edc.css" as="style"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/pages/newsdetail/_id.a37dbaf.js" as="script"><link rel="stylesheet" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/vendors.app.2feb4b5.css"><link rel="stylesheet" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/app.c4b7f37.css"><link rel="stylesheet" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/pages/newsdetail/_id.acd4edc.css"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/static/1608000886/newsdetail/5/payload.js" as="script"><link rel="preload" href="https://static.yladm.com/Transformers/yilan-web/1.0.1/static/1608000886/manifest.js" as="script">
  </head>
  <body>
    <div data-server-rendered="true" id="__nuxt"><!----><div id="__layout"><div><section id="components-layout-demo-top" class="layout ant-layout"><header class="ant-layout-header"><div class="logo"></div> <ul role="menu" class="ant-menu ant-menu-horizontal ant-menu-root ant-menu-light" style="line-height:64px"><li role="menuitem" class="ant-menu-submenu ant-menu-submenu-horizontal ant-menu-overflowed-submenu" style="display:none"><div aria-haspopup="true" class="ant-menu-submenu-title"><span>···</span><i class="ant-menu-submenu-arrow"></i></div></li><li role="menuitem" class="ant-menu-item"><a href="/" class="nuxt-link-active">首页</a></li><li role="menuitem" class="ant-menu-submenu ant-menu-submenu-horizontal ant-menu-overflowed-submenu" style="display:none"><div aria-haspopup="true" class="ant-menu-submenu-title"><span>···</span><i class="ant-menu-submenu-arrow"></i></div></li><li role="menuitem" class="ant-menu-item"><a href="/product">产品中心</a></li><li role="menuitem" class="ant-menu-submenu ant-menu-submenu-horizontal ant-menu-overflowed-submenu" style="display:none"><div aria-haspopup="true" class="ant-menu-submenu-title"><span>···</span><i class="ant-menu-submenu-arrow"></i></div></li><li role="menuitem" class="ant-menu-item"><a href="/news">新闻中心</a></li><li role="menuitem" class="ant-menu-submenu ant-menu-submenu-horizontal ant-menu-overflowed-submenu" style="display:none"><div aria-haspopup="true" class="ant-menu-submenu-title"><span>···</span><i class="ant-menu-submenu-arrow"></i></div></li><li role="menuitem" class="ant-menu-item"><a href="/information">信息报告</a></li><li role="menuitem" class="ant-menu-submenu ant-menu-submenu-horizontal ant-menu-overflowed-submenu" style="display:none"><div aria-haspopup="true" class="ant-menu-submenu-title"><span>···</span><i class="ant-menu-submenu-arrow"></i></div></li><li role="menuitem" class="ant-menu-item"><a href="/about">关于我们</a></li><li role="menuitem" class="ant-menu-submenu ant-menu-submenu-horizontal ant-menu-overflowed-submenu" style="visibility:hidden;position:absolute"><div aria-haspopup="true" class="ant-menu-submenu-title"><span>···</span><i class="ant-menu-submenu-arrow"></i></div></li></ul></header> <main class="ant-layout-content mt"><div class="news-wrap" data-v-2df07820><div class="news-wrap__box" data-v-2df07820><div class="news-wrap__box--title" data-v-2df07820>6科济生物CT053全人抗BCMA CAR T细胞注射液纳入突破性治疗品种</div> <div class="news-wrap__box--source" data-v-2df07820>来源： 美通社 2020-12-09</div> <div class="news-wrap__box--article" data-v-2df07820><p data-v-2df07820>
         12月8日，科济生物宣布，其CT053全人抗BCMA自体CAR T细胞注射液通过CDE公示期，纳入突破性治疗药物品种，拟定适应症为复发难治性多发性骨髓瘤(R/R MM)。
      </p><p data-v-2df07820>
        CT053获得突破性治疗信息
      </p><p data-v-2df07820>
        CT053是一种针对B细胞成熟抗原(BCMA)的CAR T细胞疗法。CT053构建体利用全人抗BCMA单链抗体域，推测可以降低免疫原性并提高安全性。CT053 被认为可以识别、结合和清除表达BCMA的多发性骨髓瘤细胞。
      </p><p data-v-2df07820>
        在近日举办的第62届美国血液学学会(ASH)年会上，科济生物发布了CT053正在进行的全球临床研究的最新安全性和有效性结果，包括2篇口头报告和1篇壁报交流。三项研究共涵盖来自中国和美国的58名R/R MM患者，结果显示CT053具有良好的耐受性，并且在经历了多线治疗失败的患者中观察到了显著和持久的缓解。 
      </p><p data-v-2df07820>
        值得一提的是，CT053是中国首个获得美国FDA的再生医学先进疗法(RMAT)的细胞治疗候选药物，并被欧洲药品管理局纳入优先药物(PRIME)计划。
      </p><p data-v-2df07820>
         注：原文有删减 
      </p></div> <p class="news-wrap__box--statement" data-v-2df07820>*声明：本文由作者撰写，观点仅代表作者本人，不代表公司立场。</p></div></div></main> <footer class="ant-layout-footer" style="text-align:center">
      北京一览科技有限公司 《互联网药品信息服务资格证书》的证书编号：XXXXXX
      联系我们：11102938
    </footer></section></div></div></div><script>window.__NUXT__={staticAssetsBase:"https://static.yladm.com/Transformers/yilan-web/1.0.1/static/1608000886",layout:"default",error:null,serverRendered:!0,routePath:"/newsdetail/5",config:{}}</script><script src="https://static.yladm.com/Transformers/yilan-web/1.0.1/runtime.c707a1a.js" defer></script><script src="https://static.yladm.com/Transformers/yilan-web/1.0.1/pages/newsdetail/_id.a37dbaf.js" defer></script><script src="https://static.yladm.com/Transformers/yilan-web/1.0.1/commons.app.5f7b08b.js" defer></script><script src="https://static.yladm.com/Transformers/yilan-web/1.0.1/vendors.app.fcf2fc9.js" defer></script><script src="https://static.yladm.com/Transformers/yilan-web/1.0.1/app.9269d96.js" defer></script>
  </body>
</html>
